NO960148L - Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike - Google Patents

Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike

Info

Publication number
NO960148L
NO960148L NO960148A NO960148A NO960148L NO 960148 L NO960148 L NO 960148L NO 960148 A NO960148 A NO 960148A NO 960148 A NO960148 A NO 960148A NO 960148 L NO960148 L NO 960148L
Authority
NO
Norway
Prior art keywords
carbostyrils
coumarins
preparation
drug containing
novel
Prior art date
Application number
NO960148A
Other languages
English (en)
Norwegian (no)
Other versions
NO960148D0 (no
Inventor
Walter-Gunar Friebe
Wolfgang Schaefer
Werner Scheuer
Ulrich Tibes
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO960148D0 publication Critical patent/NO960148D0/no
Publication of NO960148L publication Critical patent/NO960148L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO960148A 1993-07-13 1996-01-12 Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike NO960148L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4323409A DE4323409A1 (de) 1993-07-13 1993-07-13 Verwendung von Cumarinen und Carbostyrilen als PLA¶2¶-Inhibitoren, neue Cumarine und Carbostyrile, Verfahren zu ihrer Herstellung und Arzneimittel
PCT/EP1994/002251 WO1995002588A1 (de) 1993-07-13 1994-07-09 Verwendung von cumarinen und carbostyrilen als pla2-inhibitoren, neue cumarine und carbostyrile, verfahren zu ihrer herstellung und arzneimittel

Publications (2)

Publication Number Publication Date
NO960148D0 NO960148D0 (no) 1996-01-12
NO960148L true NO960148L (no) 1996-03-12

Family

ID=6492685

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960148A NO960148L (no) 1993-07-13 1996-01-12 Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike

Country Status (16)

Country Link
US (1) US5716983A (cs)
EP (1) EP0708766B1 (cs)
JP (1) JPH08512057A (cs)
KR (1) KR960703887A (cs)
CN (1) CN1130381A (cs)
AT (1) ATE161010T1 (cs)
AU (1) AU686197B2 (cs)
CA (1) CA2167071A1 (cs)
CZ (1) CZ6896A3 (cs)
DE (2) DE4323409A1 (cs)
FI (1) FI960149A7 (cs)
HU (1) HUT73764A (cs)
NO (1) NO960148L (cs)
NZ (1) NZ268608A (cs)
RU (1) RU2133745C1 (cs)
WO (1) WO1995002588A1 (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513555A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー 非リウマチ様関節炎の処置方法
BR9910095A (pt) 1998-05-01 2000-12-26 Lilly Co Eli Compostos inibidores de spla2 para tratamento de doença
CA2356986A1 (en) * 1998-12-30 2000-07-06 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
US6291456B1 (en) 1998-12-30 2001-09-18 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
US6331562B1 (en) 1998-12-30 2001-12-18 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
GB9920912D0 (en) * 1999-09-03 1999-11-10 Indena Spa Novel derivatives of flavones,xanthones and coumarins
US7027092B2 (en) * 2001-09-17 2006-04-11 Hewlett-Packard Development Company, L.P. Image capture and storage device
JP4746840B2 (ja) * 2002-04-26 2011-08-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド アンドロゲン受容体モジュレーターとしての２−（キノロニル）−縮合複素環化合物
KR20040001144A (ko) * 2002-06-27 2004-01-07 김대경 신규한 적혈구 세포질형 포스포리파아제 에이 투 효소,그에 대한 항체, 이들의 용도 및 제조 방법
US7538233B2 (en) * 2003-09-05 2009-05-26 Aventis Pharmaceuticals Inc. Coumarins as iNOS inhibitors
DE102004063910B4 (de) * 2004-07-05 2006-12-28 Bioplanta Arzneimittel Gmbh Trisubstituierte Benzopyranone sowie diese enthaltende Pflanzenextrakte und Mittel
CN102532015B (zh) * 2012-01-18 2013-10-23 云南大学 香豆素及其类似物的固相合成方法
CN105687184A (zh) * 2016-04-06 2016-06-22 梁海月 蛇床子素在制备治疗溃疡性结肠炎的药物方面的应用
CN111423450B (zh) * 2020-04-29 2021-10-26 上海天马有机发光显示技术有限公司 化合物、显示面板以及显示装置

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU175622A (cs) *
FR2035M (fr) * 1962-06-29 1963-09-23 Dausse Lab Médicament a base de dérivé du méthyl-4 esculétol.
BE734121A (cs) * 1968-06-14 1969-11-17
GB1432809A (en) * 1973-04-19 1976-04-22 Beecham Group Ltd Coumarin derivatives
FR2276819A1 (fr) * 1974-07-05 1976-01-30 Fabre Sa Pierre Facteurs p lipophile a action anti-inflammatoire locale utilisables dans le traitement de syndromes dermatologiques
US4136192A (en) * 1975-09-23 1979-01-23 Beecham Group Limited 4-hydroxy-3-nitro (cyano) coumarins
US4210667A (en) * 1979-04-19 1980-07-01 Pfizer Inc. Pharmaceutical preparations containing coumarin carboxylic acid derivatives
JPS6056985A (ja) * 1983-09-08 1985-04-02 Sankyo Co Ltd クマリン誘導体
DE3568773D1 (en) * 1984-05-24 1989-04-20 Ciba Geigy Ag Resorcin ethers
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
DE3427985A1 (de) * 1984-07-28 1986-01-30 Boehringer Mannheim Gmbh, 6800 Mannheim Neue 2h-l-benzopyran-2-on-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US5124334A (en) * 1987-11-30 1992-06-23 Du Pont Merck Pharmaceutical Company Benzylalcohol phospholipase A2 inhibitors
FR2677023B1 (fr) * 1991-05-30 1994-02-25 Eurobio Laboratoires Derives de coumarine hydrosolubles, leur preparation et leur utilisation comme substrat d'enzyme.
JPH06312925A (ja) * 1993-03-02 1994-11-08 Kureha Chem Ind Co Ltd 軟骨保護剤及び新規エスクレチン誘導体
AU674779B2 (en) * 1993-10-01 1997-01-09 Shionogi & Co., Ltd. Novel carboxylate derivatives exhibiting phospholipase A2 inhibitory activity

Also Published As

Publication number Publication date
HUT73764A (en) 1996-09-30
CN1130381A (zh) 1996-09-04
US5716983A (en) 1998-02-10
RU2133745C1 (ru) 1999-07-27
JPH08512057A (ja) 1996-12-17
FI960149A0 (fi) 1996-01-12
ATE161010T1 (de) 1997-12-15
EP0708766B1 (de) 1997-12-10
NZ268608A (en) 1997-09-22
WO1995002588A1 (de) 1995-01-26
EP0708766A1 (de) 1996-05-01
AU7188094A (en) 1995-02-13
FI960149L (fi) 1996-01-12
AU686197B2 (en) 1998-02-05
DE59404786D1 (de) 1998-01-22
HU9503973D0 (en) 1996-03-28
KR960703887A (ko) 1996-08-31
CA2167071A1 (en) 1995-01-26
NO960148D0 (no) 1996-01-12
CZ6896A3 (en) 1996-04-17
FI960149A7 (fi) 1996-01-12
DE4323409A1 (de) 1995-01-19

Similar Documents

Publication Publication Date Title
NO960148L (no) Anvendelse av kumariner og karbostyriler som PLA2-inhibitorer, nye kumariner og karbostyriler, fremgangsmåte for fremstilling samt legemiddel inneholdende slike
AU2003215753A1 (en) Imidazopyridine derivatives as kinase inhibitors
NO941611L (no) Nye aminosyrederivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende disse forbindelser
NO923466L (no) Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser
NO933248L (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
NO920957L (no) Cykliske urinstoffderivater og legemidler inneholdende disse forbindelser
TNSN06064A1 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
MY117557A (en) 1-(1,2-disubstituted piperidinyl)-4- substituted piperidine derivatives
ATE133667T1 (de) Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DK0707591T3 (da) Methylphosphonsyreestere, fremgangsmåde til deres fremstilling samt deres anvendelse
BRPI0307351B8 (pt) composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto
TNSN05278A1 (en) Inhibitors of phosphatidylinositol 3-kinase
NO972881L (no) Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling
GEP20033028B (en) Heterocyclic Compounds as Inhibitors of Rotamase Enzymes, Method for Their Production, Pharmaceutical Composition Containing Them and Use Thereof
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
DE69332259D1 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
CA2136553A1 (en) 7-(2-aminoethyl)-Benzothiazolones
NZ333591A (en) Thiazole compounds, process of manufacture and their use for treating prophylaxis and other diseases
DE3767839D1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
NO20060146L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
NO880811L (no) Krystalliserte cefam-syreaddisjonssalter og fremgangsmaatetil deres fremstilling.
ES8800214A1 (es) Procedimiento para preparar derivados de bencimidazol substituidos
NO975402L (no) Nye benzopyran forbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
NO933558L (no) Benzimidazoler, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application